4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-22-012955
Chief Technology Officer acquired 53,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HANLY ANN M. Chief Technology Officer | 2022-02-22 | Grant or award | +53,500 | 84,100 | D | ||
| Derivatives | |||||||
| HANLY ANN M. Chief Technology Officer | 2022-02-22 | Grant or award · Stock Option (Right to Buy) | +47,000 | 47,000 | D | ||
Loading xslF345X03/doc4.xml…